Cantor Fitzgerald analysts paint a grim picture for equity markets (SP500), (COMP:IND), (DJI), pointing to significantly ...

Cantor Fitzgerald assumed coverage of Bristol Myers (BMY) with a Neutral rating and $55 price target Following the Cobenfy for schizophrenia approval and competitor muscarinic setbacks, Bristol’s ...

Cantor Fitzgerald initiated or transferred coverage on 10 large-cap U.S. biopharma stocks in a note Tuesday, highlighting a selective approach that favors dominant franchises with strong growth ...

Fintel reports that on April 22, 2025, Cantor Fitzgerald initiated coverage of Eli Lilly and (NYSE:LLY) with a Overweight ...

An earnings preview of Tesla shows the company has missed Street estimates for revenue and earnings per share in six of the ...

As previously reported, Cantor Fitzgerald downgraded Amgen (AMGN) to Neutral from Overweight with a price target of $305, down from $340, as ...

Cantor Fitzgerald analysts renewed their criticism of U.S. Health Secretary Robert F. Kennedy Jr. on Thursday, saying the layoffs at the Food and Drug Administration pose a risk to public safety and ...

Donald Trump’s inaugural committee raised a record amount of cash, collecting $239 million from corporations and wealthy ...

Verve Therapeutics (VERV) stock surged as promising trial data for cholesterol therapy VERVE-102 prompted Cantor Fitzgerald ...

Commuter air travel has always been something of a pipe dream. While small airfields and heliports capable of operating light ...

Howard Lutnick was a Wall Street power player. Running the financial-services firm Cantor Fitzgerald, he amassed an estimated ...